Home Tags Antibody-drug conjugate

Tag: antibody-drug conjugate

Gemtuzumab Ozogamicin Granted Positive Opinion for Treatment of Previously Untreated, De...

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted positive opinions recommending that two Pfizer hematology...

Lifastuzumab Vedotin is Well-tolerated + Improves Objective Response Rate in Phase...

Lifastuzumab vedotin, also known as DNIB0600A (RO5541081) and RG-7599, is an antibody-drug conjugate or ADC.In clinical trials the investigational drug is compared to pegylated...
Featured Image: Nyhavn, Copenhagen, Denmark. Courtesy: © Fotolia. Used with permission.

University of Copenhagen’s Spin-out company ADCendo to Explore and Commercialize Novel...

Earlier this year spin-out company ADCendo, the University of Copenhagen and the Capital Region of Denmark entered into a worldwide license agreement to develop...

Annual World ADC Awards 2017: And the Winner is…

Earlier this month, the 8th World ADC meeting, held September 20 - 22, 2017 in San Diego and organized by Hanson Wade, offered a...

Registration of Antibody Drug Conjugates

Abstract      Antibody Drug Conjugates (ADC) are a rapidly expanding area of pharma company pipelines. They combine the targeting of an antibody with the potency...
Featured Image: Laboratory Glass works. Courtesy: © 2010 - 2018. Fotolia Used with permission.

Antibody-drug Conjugates: Intracellular Trafficking of New Anticancer Therapeutics

A new article, published by a team of writers including Muhammad Kalim, Jie Chen, and Shenghao Wang from the Department of Biochemistry and Genetics,...
Featured Image: Laboratory Glass works. Courtesy: © 2010 - 2018. Fotolia Used with permission.

TAK-264 (MLN0264) in Previously Treated Patients with Advanced or Metastatic Pancreatic...

Authors: Almhanna K, Wright D, Mercade TM, Van Laethem JL, Gracian AC,Guillen-Ponce C, Faris J, Lopez CM, Hubner RA, Bendell J, Bols A, Feliu...

PepTalk 2017: Antibody-drug Conjugates and the Promise of Innovation

ADC or antibody-drug conjugates have recently been at the forefront of cancer research, and according to the experts presenting their latest data during the...
IgG1 monoclonal antibody (immunoglobulin)

Strategies of Targeting the Extracellular Domain of RON Tyrosine Kinase Receptor...

Authors: Zarei O, Benvenuti S, Ustun-Alkan F, Hamzeh-Mivehroud M, Dastmalchi S. Title: Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer...

Targeting Breast Cancer with more Punch

To optimize current treatment and develop methods to more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells...